Spencer Pharmaceutical
SPPH · OTC
About SPPH
- Employees
- 0
- Headquarters
- Boston, Massachusetts
- Listed
- Jan 2, 2002
- Sector
- Health Care
- Industry
- Pharmaceuticals
SPPH key statistics
- Market cap
- 294
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 139.58K
- Volume
- 216.30K
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.0001
- 52 Week low
- $0.00
Spencer Pharmaceutical (SPPH) at a glance
Spencer Pharmaceutical (SPPH) last traded at $0.00, with a market cap of 294.
Volume so far is 216.30K shares, above the average of 139.58K shares a day.
Over the past year Spencer Pharmaceutical has ranged from $0.00 to $0.0001, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as Spencer Pharmaceutical
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002−20.00%
- SHFSSHF Holdings$0.1677+86.54%
- SXTCChina SXT Pharmaceuticals$0.0762+16.69%
- SNWRSanwire$0.0003+0.00%
- OLOXOlenox Industries$1.13+53.49%
- RBNERobin Energy$1.00+151.38%
- WHLRWheeler Real Estate Investment Trust$0.4284+19.10%
- WFFWF Holding$0.0982+5.71%
- NBNDNetBrands$0.0009−9.09%
- SPCXSpace Exploration Technologies$161.87+9.53%
- SDSTStardust Power$0.018−10.00%
- SEIISharing Economy International$0.0004+0.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.50−0.57%
- CTYCITY THERAPEUTICS$20.20−3.02%
- IAMIambic Therapeutics$15.78−1.47%
- AMROAmaero$5.54−2.55%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.10−2.35%
- RTSNRetension Pharmaceuticals$16.18+0.00%
- PAXGUPine Tree Acquisition$9.96−0.17%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.51+1.60%
- RZAIROZE AI$10.59+2.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.